Richard Jenkins

Richard Jenkins (senior executive) discloses dealings in Arkema to AMF. Over a trading history stretching from 8 November 2021 to 13 November 2025, the count stands at 10 filings.

No open-market purchase appears, only 3 sales worth €1.3M. Besides market trades, the filings include 5 share grants. So far in 2025, the count stands at no purchases and 1 sale.

On 18 November 2025 came the latest disclosure, an open-market sale for €396k in Arkema. Between a trade and the moment it shows up on AMF, the median delay is 5 days. The regulation allows three business days to notify a trade (MAR article 19). Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by AMF. They describe what insiders did and are not a recommendation.